Trials / Completed
CompletedNCT03826472
Almond Butter and Fasting Glucose
Almond Butter and Fasting Glucose in Adults With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Penn State University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A two-period randomized crossover study will be conducted to determine the effect of almond butter as an evening snack on fasting blood glucose in adults with type 2 diabetes, not taking insulin.
Detailed description
Control of fasting blood glucose is a challenge for many individuals with diabetes. Researchers want to better understand how a nighttime snack can affect morning fasting blood glucose. A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 1 week. During the almond butter treatment, participants will consume 2 tbsp of almond butter per day as an evening snack. The control treatments will be a no-snack control. Fasting blood glucose, as well as glucose trends, will be measured using Continuous Glucose Monitor (CGM). Participants will also be asked to take simple cognitive tests on a study-provided smartphone each day of the study and report their daily food intake and physical activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Almond Butter | Natural almond butter |
Timeline
- Start date
- 2019-03-08
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2019-02-01
- Last updated
- 2024-04-09
- Results posted
- 2023-11-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03826472. Inclusion in this directory is not an endorsement.